We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNST:NASDAQThe Honest Company, Inc. Analysis

Data as of 2026-05-23 - not real-time

$3.41

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The Honest Company (HNST) is trading at $3.41, comfortably above its 20‑day, 50‑day and 200‑day SMAs (3.37, 3.15 and 3.11 respectively), signaling a short‑term bullish bias despite a modestly neutral RSI of 54.6. The MACD histogram is negative and the signal line is bearish, while volume has been trending down, suggesting some short‑term weakness near the $3.06 support level and a need for confirmation before a breakout toward the $4.05 resistance. Volatility remains high at 65.8% and beta exceeds 1.5**, indicating the stock is more sensitive to market swings and carries elevated price risk.
Fundamentally, the company posted a 19.7% YoY revenue decline to $352 M, yet Q1 FY2026 showed 3.9% organic growth and record gross margins of nearly 40%, reflecting operational improvements highlighted in recent earnings calls. Cash balances of $90 M comfortably cover the $11.8 M debt, and free cash flow of $48 M provides runway, though profitability remains negative with a –5.4% net margin and a –10.8% ROE. The DCF‑derived fair value of $6.40 suggests roughly 19% upside, and analysts (median target $4.00) are upgrading earnings expectations, supporting a “buy” consensus despite the current lack of dividend distribution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bearish MACD signal
  • Decreasing volume indicating reduced short‑term momentum
  • High volatility and beta increase price risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus upgrade and median target $4.00
  • Organic revenue growth and record gross margins
  • DCF upside of ~19% and strong free cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Brand positioning in consumer defensive household segment
  • Solid cash cushion and manageable debt levels
  • Potential to convert margin improvements into sustainable profitability

Key Metrics & Analysis

Financial Health

Revenue Growth-19.70%
Profit Margin-5.39%
P/E Ratio27.1
ROE-10.86%
ROA1.29%
Debt/Equity6.96
P/B Ratio2.3
Op. Cash Flow$23.6M
Free Cash Flow$48.1M

Technical Analysis

TrendBullish
RSI54.6
Support$3.06
Resistance$4.05
MA 20$3.37
MA 50$3.15
MA 200$3.11
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$6.40
Target Price$4.07
Upside/Downside19.26%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.54
Volatility65.75%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.